Showing results (631-640 of 639) with videos related to
Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 639 results.
Journal of Medicinal Chemistry|April 18, 2014
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonistAgustin Casimiro-Garcia, David W Piotrowski, Catherine Ambler, et al.Nature Communications|February 13, 2021
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohortsRebecca E Graff, Taylor B Cavazos, Khanh K Thai, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Evaluation of aminohydantoins as a novel class of antimalarial agentsMarvin J Meyers, Micky D Tortorella, Jing Xu, et al.Bioorganic & Medicinal Chemistry|March 24, 2015
Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agentsMarvin J Meyers, Elizabeth J Anderson, Sarah A McNitt, et al.The Journal of Urology|September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional CohortLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.The Journal of Clinical Investigation|May 16, 2019
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cellsDarja Karpova, Michael P Rettig, Julie Ritchey, et al.Circulation. Cardiovascular Genetics|January 1, 2013
Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) studyErvin R Fox, Solomon K Musani, Maja Barbalic, et al.Journal of Medicinal Chemistry|August 22, 2018
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistMark E Schnute, Mattias Wennerstål, Jennifer Alley, et al.HGG Advances|January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J Meyers, Adaeze A Emeka, et al.Pageof 64